ELEKTA B

Elekta's new chief executive is replacing three top executives, including the finance chief, in a broad management overhaul aimed at improving the Swedish medical-device maker's performance.

Elekta AB has introduced a new long-term incentive plan that ties executive bonuses to the sales of its advanced radiation-therapy technology, a move approved at its annual general meeting on Thursday.

Elekta AB reported a drop in first-quarter sales and profit margins, setting a challenging backdrop for incoming Chief Executive Jakob Just-Bomholt.

Elekta AB said it received U.S. regulatory clearance for its Leksell Gamma Knife radiosurgery system to treat a form of drug-resistant epilepsy in adults.

Swedish medical technology company Elekta has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.

Elekta announced Monday that its Board of Directors has appointed Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.